| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| Evidence for a transcriptional activation function of BRCA1 C-terminal region ANA Monteiro, A August, H Hanafusa Proceedings of the National Academy of Sciences 93 (24), 13595-13599, 1996 | 633 | 1996 |
| A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer–predisposition genes DF Easton, AM Deffenbaugh, D Pruss, C Frye, RJ Wenstrup, ... The American Journal of Human Genetics 81 (5), 873-883, 2007 | 519 | 2007 |
| BRCA1 regulates p53-dependent gene expression T Ouchi, ANA Monteiro, A August, SA Aaronson, H Hanafusa Proceedings of the National Academy of Sciences 95 (5), 2302-2306, 1998 | 519 | 1998 |
| Principles for the post-GWAS functional characterization of cancer risk loci ML Freedman, ANA Monteiro, SA Gayther, GA Coetzee, A Risch, C Plass, ... Nature genetics 43 (6), 513-518, 2011 | 517 | 2011 |
| Integrated Evaluation of DNA Sequence Variants of Unknown Clinical Significance: Application to< i> BRCA1</i> and< i> BRCA2</i> DE Goldgar, DF Easton, AM Deffenbaugh, ANA Monteiro, SV Tavtigian, ... The American Journal of Human Genetics 75 (4), 535-544, 2004 | 444 | 2004 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 415 | 2013 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 392 | 2017 |
| ENIGMA—evidence‐based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with … AB Spurdle, S Healey, A Devereau, FBL Hogervorst, ANA Monteiro, ... Human mutation 33 (1), 2-7, 2012 | 325 | 2012 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 306 | 2015 |
| A review of a multifactorial probability‐based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS) NM Lindor, L Guidugli, X Wang, MP Vallée, ANA Monteiro, S Tavtigian, ... Human mutation 33 (1), 8-21, 2012 | 240 | 2012 |
| PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ... Journal of medical genetics 53 (12), 800-811, 2016 | 238 | 2016 |
| BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance DM Eccles, G Mitchell, ANA Monteiro, R Schmutzler, FJ Couch, ... Annals of oncology 26 (10), 2057-2065, 2015 | 214 | 2015 |
| A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC MJ Schell, M Yang, JK Teer, FY Lo, A Madan, D Coppola, ANA Monteiro, ... Nature communications 7 (1), 11743, 2016 | 208 | 2016 |
| Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families J Vallon-Christersson, C Cayanan, K Haraldsson, N Loman, ... Human molecular genetics 10 (4), 353-360, 2001 | 201 | 2001 |
| Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types SP Kar, J Beesley, A Amin Al Olama, K Michailidou, J Tyrer, ZS Kote-Jarai, ... Cancer discovery 6 (9), 1052-1067, 2016 | 188 | 2016 |
| Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays MS Lee, R Green, SM Marsillac, N Coquelle, RS Williams, T Yeung, ... Cancer research 70 (12), 4880-4890, 2010 | 180 | 2010 |
| Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ... Nature communications 4 (1), 1628, 2013 | 178 | 2013 |
| Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer SM Domchek, J Tang, J Stopfer, DR Lilli, N Hamel, M Tischkowitz, ... Cancer discovery 3 (4), 399-405, 2013 | 175* | 2013 |
| A guide for functional analysis of BRCA1 variants of uncertain significance GA Millot, MA Carvalho, SM Caputo, MPG Vreeswijk, MA Brown, M Webb, ... Human mutation 33 (11), 1526-1537, 2012 | 165 | 2012 |
Marcelo Alex de CarvalhoProfessor, Instituto Federal do Rio de JaneiroVerified email at ifrj.edu.br
